166 related articles for article (PubMed ID: 25196797)
21. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.
Li Y; Tang K; Zhang Z; Zhang M; Zeng Z; He Z; He L; Wan C
Mol Biol Rep; 2011 Jun; 38(5):3243-52. PubMed ID: 20177792
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of apolipoprotein E gene ε2/ε3/ε4 polymorphism for gallbladder stone disease.
Xue P; Niu WQ; Jiang ZY; Zheng MH; Fei J
PLoS One; 2012; 7(9):e45849. PubMed ID: 23049877
[TBL] [Abstract][Full Text] [Related]
23. Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.
Jiang Y; Ma L; Han C; Liu Q; Cong X; Xu Y; Zhao T; Li P; Cao Y
J Diabetes Res; 2017; 2017():3560920. PubMed ID: 28326331
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
[TBL] [Abstract][Full Text] [Related]
25. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2 diabetes.
Satirapoj B; Supasyndh O; Dispan R; Punpanich D; Tribanyatkul S; Choovichian P
J Med Assoc Thai; 2013 Sep; 96(9):1119-26. PubMed ID: 24163986
[TBL] [Abstract][Full Text] [Related]
27. Association of ApoE gene with type 2 diabetic nephropathy in a Chinese population: a meta-analysis of case-control studies.
Zhang C; Li S; Zhang X; Liu H; Luo Y
Ann Endocrinol (Paris); 2015 Oct; 76(5):601-13. PubMed ID: 25669588
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E gene variants on the risk of end stage renal disease.
Xue C; Nie W; Tang D; Yi L; Mei C
PLoS One; 2013; 8(12):e83367. PubMed ID: 24349494
[TBL] [Abstract][Full Text] [Related]
29. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
Araki S; Moczulski DK; Hanna L; Scott LJ; Warram JH; Krolewski AS
Diabetes; 2000 Dec; 49(12):2190-5. PubMed ID: 11118024
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E gene polymorphism and the risk of subarachnoid hemorrhage: a meta-analysis of case-control studies.
Zhao D; Zhang Z; Wu GB; Wang HY; Gao F; Duan XD; Lu YY; Wang ZM; You DP; Qu Y; Song J
Acta Neurochir (Wien); 2016 Aug; 158(8):1515-22. PubMed ID: 27241684
[TBL] [Abstract][Full Text] [Related]
31. Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies.
Yin YW; Sun QQ; Zhang BB; Hu AM; Liu HL; Wang Q; Hou ZZ
PLoS One; 2013; 8(6):e66924. PubMed ID: 23826174
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients.
Morbois-Trabut L; Chabrolle C; Garrigue MA; Lasfargues G; Lecomte P
Diabetes Metab; 2006 Jun; 32(3):270-5. PubMed ID: 16799405
[TBL] [Abstract][Full Text] [Related]
33. 4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy.
Xue C; Nie W; Zhou C; Yu F; Wang DM; Dai B; Mei CL
Ren Fail; 2014 Apr; 36(3):332-8. PubMed ID: 24345290
[TBL] [Abstract][Full Text] [Related]
34. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.
Jiang Y; He T; Deng W; Sun P
Clin Interv Aging; 2017; 12():1941-1949. PubMed ID: 29180857
[TBL] [Abstract][Full Text] [Related]
35. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
[TBL] [Abstract][Full Text] [Related]
37. BsmI polymorphisms in vitamin D receptor gene are associated with diabetic nephropathy in type 2 diabetes in the Han Chinese population.
Zhang H; Wang J; Yi B; Zhao Y; Liu Y; Zhang K; Cai X; Sun J; Huang L; Liao Q
Gene; 2012 Mar; 495(2):183-8. PubMed ID: 22245613
[TBL] [Abstract][Full Text] [Related]
38. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
[TBL] [Abstract][Full Text] [Related]
39. Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis.
Liang Y; Zhou Z; Wang H; Cheng X; Zhong S; Zhao C
Epilepsy Behav; 2019 Sep; 98(Pt A):27-35. PubMed ID: 31299529
[TBL] [Abstract][Full Text] [Related]
40. Association study between apolipoprotein E gene polymorphism and diabetic nephropathy in a Taiwanese population.
Wen MJ; Lin CJ; Hung YJ; Pei D; Kuo SW; Hsieh CH
Genet Test Mol Biomarkers; 2011 Oct; 15(10):685-9. PubMed ID: 21689001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
